chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out; felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out; flu-sick from head to toe; Migraine; Headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out), ILLNESS (felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out), INFLUENZA LIKE ILLNESS (flu-sick from head to toe), MIGRAINE (Migraine) and HEADACHE (Headache) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-sick from head to toe), MIGRAINE (Migraine), HEADACHE (Headache) and NAUSEA (nausea). On 14-May-2021, the patient experienced DIARRHOEA (felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out) and ILLNESS (felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out), ILLNESS (felt sick sick sick and had a severe episode of diarrhea where she felt all flushed out), INFLUENZA LIKE ILLNESS (flu-sick from head to toe), MIGRAINE (Migraine), HEADACHE (Headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were added.
Moderate to severe pain in left arm, unable to perform all work duties, paresthesia L arm, feeling cold in L forearm, generalized body aches continuing 3 days so far, generalized fatigue.
COVID BREAKTHROUGH CASE. May 17 I tested positive for COVID with a home test. Because of my age and I had a heart attack about 4 years ago so for this reason I felt I needed the antiviral medication. I called my PCP and the assistant redirected me to the local urgent care for a virtual appointment. I connected with the PA and she asked a serious of questions and she confirmed that the test was positive and she prescribed PAXLOVID. I did isolate for 7 days No resp. issues. Headaches and a little ache and tired and this would just come and go. A week before my wife and I traveled.
No additional AE/PQC; She received the GARDASIL vaccine in July 2013 (first dose) and 2014 (second dose). Patient did not mention that she ever received the third dose ofGARDASIL.; This spontaneous report was received from a female patient of unknown age reporting on herself. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  In July 2013, patient was vaccinated with her first dose, and on an unknown date in 2014 ,with the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) (strength, route, dose, frequency, anatomical location,lot # and expiration date were unknown) for prophylaxis.   The patient did not mention that she ever received the third dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL). No additional adverse events were reported.
blood clots in both lungs; blood clots in left leg; shortness of breath; after the administration her arm hurt really bad; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY THROMBOSIS (blood clots in both lungs) and THROMBOSIS (blood clots in left leg) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE PAIN (after the administration her arm hurt really bad). On 15-Apr-2021, the patient experienced PULMONARY THROMBOSIS (blood clots in both lungs) (seriousness criteria hospitalization and medically significant) and THROMBOSIS (blood clots in left leg) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced DYSPNOEA (shortness of breath). The patient was hospitalized from 15-Apr-2021 to 18-Apr-2021 due to PULMONARY THROMBOSIS and THROMBOSIS. On 01-Apr-2021, VACCINATION SITE PAIN (after the administration her arm hurt really bad) had resolved. At the time of the report, PULMONARY THROMBOSIS (blood clots in both lungs), THROMBOSIS (blood clots in left leg) and DYSPNOEA (shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. The patient received Apixaban as a treatment medication for blood clots.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.  .
Patient given her 2nd Pfizer vaccine 7 days before the recommended time between the 1st and 2nd dose.
Information has been received from a pharmacist concerning a female who on 26-JUL-2007 was vaccinated SQ with 0.65 mL of Zostavax (Oka/Merck).  Subsequently the patient experienced peeling of the skin around her lips and when the skin is pulled off, the area starts to bleed.  As of 07-AUG-2007, the patient had not recovered.  Medical attention was sought.  Additional information has been requested. 12/21/2007 This is in follow-up to report(s) previously submitted on 9/24/2007. Follow-up information was received from the pharmacist indicating that the patient was vaccinated SQ in the right deltoid with 0.65 mL of ZOSTAVAX (Oka/Merck) (lot# 657676/0619U). No further information is expected.
L arm pain since Dec 9th. Had seasonal flu and H1N1 vaccines that day. The H1N1 was given in L deltoid. Denies egg allergy.
This spontaneous report as received from a nurse refers to three patients (dates of birth, age and gender unspecified). The nurse reported that the patients received third doses of GARDASIL 0.5 ml intramuscular, (lot# and exp date unspecified) in less than 12 week interval between doses. No adverse effects required. Patients outcomes were unknown. This is one of two reports from the same reporter. MARRS: 1308USA003872. Additional information has been requested.
had vomits; muscle and joint pain; Muscle and joint pain; Headache; This case was reported by a consumer via call center representative and described the occurrence of myalgia in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th November 2020, the patient received Shingrix. On 11th November 2020, less than a day after receiving Shingrix, the patient experienced myalgia, headache and joint pain. On 12th November 2020, the patient experienced vomiting. On an unknown date, the outcome of the myalgia and joint pain were unknown and the outcome of the headache was not recovered/not resolved and the outcome of the vomiting was recovered/resolved.   It was unknown if the reporter considered the myalgia, headache, vomiting and joint pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix vaccine and same day experienced headache, muscle and joint pain, the next day had vomits, 4 times and the headache continued.  The patient mentioned she visit her doctor and he said it was an adverse reaction to Shingrix The reporter consented to follow up and no vaccine data provided.
Soreness right arm onset day of injection progressively got worse each day. No redness, no fever, entire arm hurts since injection, pain seems to radiate from site of injection. Worse today than yesterday. No HX arthritis or difficulty moving arm prior to injection.
Patient experienced itchness and tightness in throat but had no trouble swallowing. She was given 25 mg of benadryl & water. Onsite EMS was called vitals HR 85 BP 171/87. Patient had similar experience at the 1st dose. Patient waited and symptom subsided and left at 5:45pm
Patient experienced discomfort and reported feeling her lips swelling. Administered 20 mL of liquid Benadryl. Observation period increased. Observed pulse and respirations. Swelling subsided.
Pt was hospitalized with A.fib with  rapid ventricular response on 4.15, 3 days after receiving the vaccine. Per guidelines, all hospitalizations  should be reported.
left arm is still very sore; still doesn't have full range of motion without a lot of pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (still doesn't have full range of motion without a lot of pain) and VACCINATION SITE PAIN (left arm is still very sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical records).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (still doesn't have full range of motion without a lot of pain). On an unknown date, the patient experienced VACCINATION SITE PAIN (left arm is still very sore). At the time of the report, ABDOMINAL DISCOMFORT (still doesn't have full range of motion without a lot of pain) and VACCINATION SITE PAIN (left arm is still very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
13 hours after receiving the injection I had body aches all over that lasted 8 hours and then just went away.
Pfizer-BioNTech COVID-19 Vaccine EUA  Beginning the day of vaccine, very sore upper left arm for 2 days. Moderate headache beginning on day after vaccine, lasting for one day.
Chest pain- pericarditis. Elevated troponin. Heart cath. PCU hospital admit. No previous heart hx. Ekg abnormal. Echo, mri.
At first I just felt tired but after I fell asleep I woke up in a cold sweat feeling extremely nauseated and dizzy. I vomited that morning and once more that afternoon. The entire day (August 3rd) I felt feverish and nauseous.
Chills about 12 hours after vaccine, and fever of 100.8 a few hours later
nausea; tiredness; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), FATIGUE (tiredness), CHILLS (chills) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Breast cancer.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced NAUSEA (nausea), FATIGUE (tiredness), CHILLS (chills) and PYREXIA (fever). On 06-Mar-2021, NAUSEA (nausea), FATIGUE (tiredness), CHILLS (chills) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient have event like hard spot, rashy arms, shaking chills.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: initial follow up
Significant pain at the time of injection. Within about 20 minutes, I was experiencing extreme pain that traveled down my right arm and lasted for about 10 hours. It is now two weeks later, and I am still experiencing great pain and am unable to move my right arm without a great deal of pain and major discomfort.
First thing is COVID-19 infection. the Patient's husband recently died, and her whole immediate family developed COVID-19 after the funeral.  She started to have symptoms yesterday.  And she tested positive this morning.  This is a home test.  The patient has a sore throat and slight cough.  She is not short of breath.  She has not had fevers.  She does have some nausea.
Patient reported feeling like her throat was closing/tighening in her throat upon returning home .  Took 1/2 Benadryl tablet and symptoms resolved on their own.
received expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number unknown, expiry date 30th September 2022) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 12-OCT-2022 Reporter's Comment: The pharmacist had reported that a dose of Boostrix was given by error on the past few days to the patient which was already expired on 30th September 2022. Lot number data was not available. No other information was available at the moment. The reporter did not consent to follow up.  Additional supportive information: The patient had received an expired dose of Boostrix, which led to expired vaccine used. This case was one of four cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2022AMR147249:same reporter US-GSK-US2022146819:same reporter US-GSK-US2022AMR147250:same reporter
Information regarding Prevnar was received from a healthcare professional regarding a 4-month-old male patient who experienced fever of 100 deg. F. At 4 months of age, the patient received the second dose on 16-Mar-2006. On 26-May-2006, the patient developed fever of 100 deg. F when he arrived to receive his third dose of Prevnar. The reporter noted that the physician did not believe the vaccine was responsible for the fever. The patient's outcome was unknown. Body temperature (results: 100 deg. F.) was done on 26-May-2006.
Hives (uteracia) Outbreaks began in scalp, very itchy. Benadryl didn?t help. Progressed to all over body and face. Each hives for last approx 1 your but move elsewhere (multiple at one time) also dermatographia -, clothes and hats leave marks on body. This has been ongoing for over 2 weeks with no improvement. High doses of antihistamines being taken. Allergy specialist convinced it?s due to delayed reaction from booster.
Fever to 100F, onset 4/16/01. (Not listed on visit). Also, arm is swollen around shot area.
Injection site pain, injection site swelling, injection site redness, shaking, chills, tiredness, headache, muscle pain, joint pain, nausea, feeling unwell, fever of 103.6
This case was reported by a consumer via call center representative and described the occurrence of pain in a 70-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received in 2018, about 3 months ago from the date of reporting). On 17th October 2018, the patient received the 2nd dose of SHINGRIX. On 17th October 2018, less than a day after receiving SHINGRIX, the patient experienced pain, cold sweat, influenza-like symptoms, shivering and nausea. On an unknown date, the outcome of the pain, cold sweat, influenza-like symptoms, shivering and nausea were not recovered/not resolved. It was unknown if the reporter considered the pain, cold sweat, influenza-like symptoms, shivering and nausea to be related to SHINGRIX. Additional details were provided as follows: This case was reported by patient's wife. After receiving 1st dose of SHINGRIX, the patient did not experience any symptoms. On 17th October 2018, the patient received the 2nd dose. On the same night, before the day of reporting, the patient experienced flu like symptoms, achiness, shivering, sweating when cold and nausea. This case has been linked with the case US2018190194 (patient's wife), reported by same reporter.
had two shots since then very painful; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles 5 times in 25 years).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient. The age group was not reported but was captured as adult as per vaccine indication.  The age at vaccination was not reported. The patient had receive 1st dose of Shingles vaccine and experienced pain. The follow-up would not possible as no contact details were available. For tolerance of 2nd dose, refer case US2021AMR095150.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR095150:same reporter
Patient started itching on her left arm, left side and around her g-tube about 5 minutes after receiving shot
pt recv vax; 3 days later noticed red pin point rash on chest and back after am shower; rash very itchy; took dph; rash cont and had spread down arms and legs; to see MD in am;
Patient developed redness, warmth, and severe itching at the site, symptoms occurred over 1 week after vaccine received.  She did use hydrocortisone cream and cool compresses which has given relief.
Severe fatigue; Weakness; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (Severe fatigue) and ASTHENIA (Weakness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Severe fatigue) and ASTHENIA (Weakness). At the time of the report, FATIGUE (Severe fatigue) and ASTHENIA (Weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), was not applicable.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 39 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "RA" (unspecified if ongoing); "known allergies:  PCN" (unspecified if ongoing), notes: known allergies:  PCN. There were no concomitant medications. Past drug history included: Plaquenil, reaction(s): "known allergies: plaquenil", notes: known allergies: plaquenil. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Negative; (May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: other medication in 2weeks: No The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
nausea; Vomiting; Stomach pain/stomach problems; This is the spontaneous report received from a contactable consumer (patient). A 75-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 29Mar2021 12:30 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  Medical history included ongoing Acid reflux. The patient was not sure if the COVID 19 vaccine flare up her acid reflux or not. It has been off and on for a few years. Prior vaccinations (within 4 weeks) was none. The patient's concomitant medications were not reported. The patient had side effects of nausea and vomiting and she still had stomach problems all on 30Mar2021. Nausea was getting better and after she ate something it helped. The patient still had stomach pains. Vomiting stopped a couple of days ago and she was not completely sure if she had recovered completely because it still comes and go. The patient did not eat anything her stomach hurt really bad. For her stomach problems she was taking Mylanta Kaopectate and it was not helping and also Pepto-Bismol. The expiry date was 20Dec2023, lot Lot: 0D167, (s) did not require a visit to Emergency Room or Physician Office. The outcome of event nausea and vomiting was recovering, and stomach pain/stomach problems was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
On February 22, 2023, I woke up and I was supposed to go running but my throat and nose felt weird. We had just run the race two days prior. I took a home COVID-19 test, and it was positive. My symptoms were minimal at first. But over the next few days I had a fever up to about 100.4 and took ibuprofen for that. I video consulted with my doctor. I was prescribed PAXLOVID. I began taking the prescription that night. My fever continued. On the 24th I noticed I lost my sense of smell, and I was congested with runny nose. I took some over-the-counter medicine for that. My fever got better, and my other symptoms were getting better. I tested positive again yesterday.
I was diagnosed with pancreatitis   i started having stomach pain saturday afternoon.  Monday I had intense stomach pain that went into my back.  went to care facility after work. they said they couldnt see me. They could get me in the next day. i was in soo much pain i said no i need to go to the ER.  drove over to er and was seen there for 6 1/2 hours . given IV fluid and liquid ibuprofen